Recruiting Heart Failure Studies in Richmond
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
This is a prospective, double-blind, sham-controlled, multicenter, randomized clinical trial is to study the effects of remote ischemic preconditioning on contrast-associated acute kidney injury, func...
The Re-Prosper HF Study
Heart failure with reduced ejection fraction (HFrEF) is a common cause for admission within the Veterans Affairs (VA) Health Care System. It is associated with severe impairment of physical and menta...
About Heart Failure Clinical Trials in Richmond
Heart failure is a chronic condition where the heart cannot pump blood efficiently to meet the body's needs. It affects millions of people worldwide and can result from various heart conditions. Treatment includes medications, lifestyle changes, devices, and in severe cases, heart transplant.
There are currently 2 heart failure clinical trials recruiting participants in Richmond, VA. These studies are seeking a combined 360 participants. Research is being sponsored by VA Office of Research and Development. Clinical trial participation is free and participants receive study-related medical care at no cost.
Heart Failure Clinical Trials in Richmond — FAQ
Are there heart failure clinical trials in Richmond?
Yes, there are 2 heart failure clinical trials currently recruiting in Richmond, VA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Richmond?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you about next steps.
Are clinical trials in Richmond free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond studies also compensate for your time and travel.
What heart failure treatments are being tested?
The 2 active trials in Richmond are testing new therapies including novel drugs, biologics, and treatment approaches for heart failure.
Data updated March 2, 2026 from ClinicalTrials.gov